The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Vitamins E and C in the Prevention of Prostate and Total Cancer in Men: The Physicians' Health Study II Randomized Controlled Trial
Open accessAbstract
CONTEXT: Many individuals take vitamins in the hopes of preventing chronic diseases such as cancer, and vitamins E and C are among the most common individual supplements. A large-scale randomized trial suggested that vitamin E may reduce risk of prostate cancer; however, few trials have been powered to address this relationship. No previous trial in men at usual risk has examined vitamin C alone in the prevention of cancer. OBJECTIVE: To evaluate whether long-term vitamin E or C supplementation decreases risk of prostate and total cancer events among men. DESIGN, SETTING, AND PARTICIPANTS: The Physicians' Health Study II is a randomized, double-blind, placebo-controlled factorial trial of vitamins E and C that began in 1997 and continued until its scheduled completion on August 31, 2007. A total of 14,641 male physicians in the United States initially aged 50 years or older, including 1307 men with a history of prior cancer at randomization, were enrolled. INTERVENTION: Individual supplements of 400 IU of vitamin E every other day and 500 mg of vitamin C daily. MAIN OUTCOME MEASURES: Prostate and total cancer. RESULTS: During a mean follow-up of 8.0 years, there were 1008 confirmed incident cases of prostate cancer and 1943 total cancers. Compared with placebo, vitamin E had no effect on the incidence of prostate cancer (active and placebo vitamin E groups, 9.1 and 9.5 events per 1000 person-years; hazard ratio [HR], 0.97; 95% confidence interval [CI], 0.85-1.09; P = .58) or total cancer (active and placebo vitamin E groups, 17.8 and 17.3 cases per 1000 person-years; HR, 1.04; 95% CI, 0.95-1.13; P = .41). There was also no significant effect of vitamin C on total cancer (active and placebo vitamin C groups, 17.6 and 17.5 events per 1000 person-years; HR, 1.01; 95% CI, 0.92-1.10; P = .86) or prostate cancer (active and placebo vitamin C groups, 9.4 and 9.2 cases per 1000 person-years; HR, 1.02; 95% CI, 0.90-1.15; P = .80). Neither vitamin E nor vitamin C had a significant effect on colorectal, lung, or other site-specific cancers. Adjustment for adherence and exclusion of the first 4 or 6 years of follow-up did not alter the results. Stratification by various cancer risk factors demonstrated no significant modification of the effect of vitamin E on prostate cancer risk or either agent on total cancer risk. CONCLUSIONS: In this large, long-term trial of male physicians, neither vitamin E nor C supplementation reduced the risk of prostate or total cancer. These data provide no support for the use of these supplements for the prevention of cancer in middle-aged and older men. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT00270647.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1994) · New England Journal of Medicine · doi:10.1056/nejm199404143301501 · Cited by 4,737
Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease
Omenn, G. S., Goodman, G. E., Thornquist, M. D., Balmes, J., Cullen, M. R., Glass, A., Keogh, J. P., Meyskens, F. L., Valanis, B., Williams, J. H., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199605023341802 · Cited by 3,638
Dietary Carcinogens and Anticarcinogens: Oxygen radicals and degenerative diseases
Ames, B. N. (1983) · Science · doi:10.1126/science.6351251 · Cited by 2,969
Clark, L. (1996) · JAMA · doi:10.1001/jama.276.24.1957 · Cited by 2,719
Hennekens, C. H., Buring, J. E., Manson, J. E., Stampfer, M., Rosner, B., Cook, N. R., Belanger, C., LaMotte, F., Gaziano, J. M., Ridker, P. M., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199605023341801 · Cited by 2,397
Self-citation(1999) · PubMed · Cited by 2,062
Blot, W. J., Li, J.-Y., Taylor, P. R., Guo, W., Dawsey, S., Wang, G.-Q., Yang, C. S., Zheng, S.-F., Gail, M., Li, G.-Y., et al. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.18.1483 · Cited by 1,760
Lee, I.-M., Cook, N. R., Gaziano, J. M., Gordon, D., Ridker, P. M., Manson, J. E., Hennekens, C. H., & Buring, J. E. (2005) · JAMA · doi:10.1001/jama.294.1.56 · Cited by 1,137
Self-citationChronic inflammation and oxidative stress in human carcinogenesis
Federico, A., Morgillo, F., Tuccillo, C., Ciardiello, F., & Loguercio, C. (2007) · International Journal of Cancer · doi:10.1002/ijc.23192 · Cited by 1,001
Hercberg, S., Galan, P., Preziosi, P., Bertrais, S., Mennen, L., Malvy, D., Roussel, A.-M., Favier, A., & Briançon, S. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.21.2335 · Cited by 956
Heinonen, O. P., Koss, L., Albanes, D., Taylor, P. R., Hartman, A. M., Edwards, B. K., Virtamo, J., Huttunen, J. K., Haapakoski, J., Malila, N., et al. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.6.440 · Cited by 918
Sesso, H. D. (2008) · JAMA · doi:10.1001/jama.2008.600 · Cited by 913
Self-citationA Clinical Trial of Antioxidant Vitamins to Prevent Colorectal Adenoma
Greenberg, E. R., Baron, J. A., Tosteson, T. D., Freeman, D. H., Beck, G. J., Bond, J. H., Colacchio, T. A., Coller, J. A., Frankl, H. D., Haile, R. W., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199407213310301 · Cited by 762
Dietary Factors and Risk of Breast Cancer: Combined Analysis of 12 Case--Control Studies
Howe, G. R., Hirohata, T., Hislop, T. G., Iscovich, J. M., Yuan, J.-M., Katsouyanni, K., Lubin, F., Marubini, E., Modan, B., Rohan, T., et al. (1990) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/82.7.561 · Cited by 750
Vitamin C and cancer prevention: the epidemiologic evidence
Block, G. (1991) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/53.1.270s · Cited by 471
Lee, I.-M., Cook, N. R., Manson, J. E., Buring, J. E., & Hennekens, C. H. (1999) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/91.24.2102 · Cited by 467
Self-citationAssociation Between alpha-Tocopherol, gamma-Tocopherol, Selenium, and Subsequent Prostate Cancer
Helzlsouer, K. J. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.24.2018 · Cited by 391
Christen, W. G., Gaziano, J. M., & Hennekens, C. H. (2000) · Annals of Epidemiology · doi:10.1016/s1047-2797(99)00042-3 · Cited by 376
Self-citationDietary Supplements in a National Survey: Prevalence of Use and Reports of Adverse Events
Timbo, B. B., Ross, M. P., McCarthy, P. V., & Lin, C.-T. J. (2006) · Journal of the American Dietetic Association · doi:10.1016/j.jada.2006.09.002 · Cited by 317
A randomized trial of vitamins C and E in the prevention of recurrence of colorectal polyps.
McKeown‐Eyssen, G., Holloway, C. M. B., Jazmaji, V., Bright‐See, E., Dion, P. W., & Bruce, W. R. (1988) · PubMed · Cited by 205
Albanes, D., Malila, N., Taylor, P. R., Huttunen, J. K., Virtamo, J., Edwards, B. K., Rautalahti, M., Hartman, A. M., Barrett, M. J., Pietinen, P., et al. (2000) · Cancer Causes & Control · doi:10.1023/a:1008936214087 · Cited by 167
Dietary antioxidants and the risk of lung cancer
(1992) · Lung Cancer · doi:10.1016/0169-5002(92)90114-y · Cited by 167
Epidemiologic evidence for vitamin C and vitamin E in cancer prevention
Byers, T., & Guerrero, N. (1995) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/62.6.1385s · Cited by 163
Diet and colorectal cancer with special reference to fiber intake
Heilbrun, L. K., Nomura, A. M. Y., Hankin, J. H., & Stemmermann, G. N. (1989) · International Journal of Cancer · doi:10.1002/ijc.2910440102 · Cited by 145
A secondary prevention trial of antioxidant vitamins and cardiovascular disease in women
Manson, J. E., Gaziano, J. M., Spelsberg, A., Ridker, P. M., Cook, N. R., Buring, J. E., Willett, W. C., & Hennekens, C. H. (1995) · Annals of Epidemiology · doi:10.1016/1047-2797(94)00091-7 · Cited by 119
Self-citationEssential micronutrients in relation to carcinogenesis
Kromhout, D. (1987) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/45.5.1361 · Cited by 116
SELECT: the Selenium and Vitamin E Cancer Prevention Trial: rationale and design
Klein, E., Thompson, I. M., Lippman, S., Goodman, P., Albanes, D., Taylor, P., & Coltman, C. A. (2000) · Prostate Cancer and Prostatic Diseases · doi:10.1038/sj.pcan.4500412 · Cited by 108
Estimating the effect of the run‐in on the power of the physicians' health study
Lang, J. M., Buring, J. E., ROSNER, B. A., Cook, N. R., & Hennekens, C. H. (1991) · Statistics in Medicine · doi:10.1002/sim.4780101010 · Cited by 99
Self-citationNutritional supplementation with antioxidants decreases chromosomal damage in humans
Dušinská, M., Kazimírová, A., Barancoková, M., Beno, M., Smolková, B., Horská, A., Raslová, K., Wsólová, L., & Collins, A. R. (2003) · Mutagenesis · doi:10.1093/mutage/geg002 · Cited by 56
Cited by
Sharifi-Rad, M., Anil Kumar, N. V., Zucca, P., Varoni, E. M., Dini, L., Panzarini, E., Rajkovic, J., Tsouh Fokou, P. V., Azzini, E., Peluso, I., et al. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00694 · Cited by 1,971
“No significant results were obtained regarding the risk of colorectal or lung cancer (Gaziano et al., 2009).”
BackgroundKlein, E. A., Thompson, I. M., Tangen, C. M., Crowley, J. J., Lucia, M. S., Goodman, P. J., Minasian, L. M., Ford, L. G., Parnes, H. L., Gaziano, J. M., et al. (2011) · JAMA · doi:10.1001/jama.2011.1437 · Cited by 1,787
Self-citationKushi, L. H., Doyle, C., McCullough, M., Rock, C. L., Demark‐Wahnefried, W., Bandera, E. V., Gapstur, S., Patel, A. V., Andrews, K., Gansler, T., et al. (2012) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20140 · Cited by 1,325
Vitamins C and E: Beneficial effects from a mechanistic perspective
Traber, M. G., & Stevens, J. F. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.05.017 · Cited by 1,076
Ascorbic acid: Chemistry, biology and the treatment of cancer
Du, J., Cullen, J. J., & Buettner, G. R. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.06.003 · Cited by 1,070
Metadata
- Authors
- Gaziano, J. M., Glynn, R. J., Christen, W. G., Kurth, T., Belanger, C., MacFadyen, J., Bubes, V., Manson, J. E., Sesso, H. D., & Buring, J. E.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2009-01-07
- Volume
- 301
- Issue
- 1
- Pages
- 52
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2169256012
- Cited by
- 518
- References
- 33
- FWCI
- 24.06
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.